We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Compliance with USP, ICH Guides on Elemental Impurities in Drugs
FDA Clarifies Compliance with USP, ICH Guides on Elemental Impurities in Drugs
The FDA is breaking down how drugmakers should comply with standards established by the International Council for Harmonization and the United States Pharmacopeia for controlling elemental impurities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor